Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.700
-0.060 (-3.41%)
At close: Mar 20, 2026, 4:00 PM EDT
1.710
+0.010 (0.59%)
After-hours: Mar 20, 2026, 6:55 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $3.81 million as of March 20, 2026. Its market cap has decreased by -66.76% in one year.
Market Cap
3.81M
Enterprise Value
-4.70M
1-Year Change
-66.76%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $3.81M, a decrease of -92.05%. That is a compound annual growth rate of -42.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 3.95M | -22.56% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 4.64M |
| Bio Green Med Solution | 4.51M |
| Revelation Biosciences | 4.46M |
| Genprex | 4.45M |
| Silo Pharma | 4.34M |
| Biodexa Pharmaceuticals | 4.25M |
| Aptevo Therapeutics | 4.21M |
| Matinas BioPharma Holdings | 3.78M |